(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SGD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SGD

ST13

US500000079193398

Class

1, 5, 40

Filing

79193398

Registration

5220416

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

55

Latest update

06/14/2026

Trademark type

Word

Nice classes

1, 5, 40

Filing date

06/02/2016

Registration date

06/13/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/11/2024

Last transaction

06/14/2026

Responsible office

United States Patent and Trademark Office

Status code

708

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

Zofingen, CH

Examiner

WHITTAKER BROWN, TRACY

Current location

FILE DESTROYED

Holders and representatives

Holders

Siegfried Holding AG

Representatives

Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.

Technical classification

Nice Classes

Class 1Class 5Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for use in industryscience and photographyas well as in agriculturehorticulture and forestry; unprocessed artificial resinsunprocessed plastics; fertilizing preparations; fire-extinguishing compositions; tempering preparations for use in and soldering ; chemical substances for preserving foodstuffs ; tanning agents for use in the manufacture of leatheroils for tanning leather; adhesives for use in industry; alkaloids for industrial purposes; Methyl and Acetic acid esters; acids

Class 5

Pharmaceuticalmedical and veterinary preparations for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldblood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Dietetic substances and foodstuffs for medical and veterinary useantidepressant for companion animalslice treatment; Disinfectantspreparations for destroying vermin; Fungicidesherbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use ; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for veterinary usefor antidepressant for companion animalslice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical usemedicated bath salts; Preparations for acne treatments; Controlled substancesprescription narcotics; Opiates; Pharmaceutical preparationsfor treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicinesulfonamides; Veterinary preparations for treatment of depression for companion animalslice treatment; Salts for medical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Pharmaceutical alcoholsmedicinal alcohols; Medicines for human medicine for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicines for veterinary use for treatment of depression for companion animalslice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injections for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infectiontreatment of depression for companion animalslice treatment and veterinary preparations for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldblood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Dietetic substances and foodstuffs for medical and veterinary useantidepressant for companion animalslice treatment; Disinfectantspreparations for destroying vermin; Fungicidesherbicides; Alkaloids for medical use; Analgesics; General anesthetics; Chemical preparations for medical use; Chemical preparations for pharmaceutical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for veterinary usefor antidepressant for companion animalslice treatment; Cellulose esters for pharmaceutical use; Hormones for medical use; Potassium salts for medical usemedicated bath salts; Preparations for acne treatments; Controlled substancesprescription narcotics; Opiates; Pharmaceutical preparationsfor treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicinesulfonamides; Veterinary preparations for treatment of depression for companion animalslice treatment; Salts for medical use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Pharmaceutical alcoholsmedicinal alcohols; Medicines for human medicines for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Medicines for veterinary use for treatment of depression for companion animalslice treatment; Medicines for dental use for local anesthetics; Chemical-pharmaceutical preparations for injectionstreatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infection; Chemical preparations for medical or veterinary use for treatment of benign prostate hyperplasiadepressionchronic myeloid leukaemiaglaucomaocular hypertensionhypertensionhypotensionasthmaschizophreniabipolar disorderdiabetesmental illnessmigrainescough and coldformation of blood clotsaddictionskin disorderscentral nervous system diseasesurinary tract infectiontreatment of depression for companion animalslice treatment

Class 40

Treatment of materials in the nature of spry dryingmillingmicronisationnitrationhydrogenationphosgenationhalogenationoxidationreduction; Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements; custom manufacture of pharmaceutical products as per customer order and in accordance with customer requirementsacetalaldehydsalkaloidsestersketonesmercaptanoxalatesacidsvitamins and ingredients used in the manufacture of medicines against cancer

Publications

History of USPTO decisions and trademark events.

55 publications found

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/13/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

03/12/2026

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

09/27/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

09/02/2025

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/01/2025

INPC

INVALIDATION PROCESSED

09/01/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/12/2025

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

09/11/2024

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

09/11/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/09/2024

ES75

TEAS SECTION 71 & 15 RECEIVED

08/03/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/23/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/05/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/13/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/30/2020

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

05/08/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

04/17/2019

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

08/17/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/09/2018

ES7R

TEAS SECTION 7 REQUEST RECEIVED

06/19/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/28/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/18/2017

FIMP

FINAL DISPOSITION PROCESSED

09/18/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/13/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

06/13/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/28/2017

PUBO

PUBLISHED FOR OPPOSITION

03/28/2017

GPNX

NOTIFICATION PROCESSED BY IB

03/25/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/08/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/08/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/08/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/21/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/09/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

02/07/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/07/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

02/07/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/07/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/26/2017

GNRT

NON-FINAL ACTION E-MAILED

01/26/2017

CNRT

NON-FINAL ACTION WRITTEN

01/26/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/10/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/10/2016

ALIE

ASSIGNED TO LIE

12/08/2016

RFNT

REFUSAL PROCESSED BY IB

11/25/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/22/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/22/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/22/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/09/2016

RFRR

REFUSAL PROCESSED BY MPU

11/09/2016

MAFR

APPLICATION FILING RECEIPT MAILED

10/18/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/15/2016

CNRT

NON-FINAL ACTION WRITTEN

10/14/2016

DOCK

ASSIGNED TO EXAMINER

10/12/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/12/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/06/2016

Continuous trademark protection

Get notified about every new filing that threatens SGD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.